Axoltis Pharma
France, Lyon, Auvergne-Rhône-Alpes
About Axoltis Pharma
Axoltis Pharma is a biopharmaceutical company focused on developing drugs for the treatment of neurodegenerative and traumatic neurological disorders. The company's main offerings include peptides designed to address medical needs in the central nervous system. Axoltis Pharma primarily caters to the healthcare sector, with a focus on patients suffering from neurological disorders. Axoltis Pharma was formerly known as Neuronax. It is based in Clermont-Ferrand, France.
Latest Funding
Series AAnnounced 2025-12-02
Buying Signals
Where the capital is going, and whether it's already started moving.
Spend Intent
2 signals · where the capital is going
Advancing novel therapeutic solutions for neurodegenerative diseases including ALS, Alzheimer and Parkinson
eu-startups.com
+1 more capital deployment signal · confidence ratings · source articles
Sign up freeSelling to Axoltis Pharma? You're in the right place.
Knowing they raised is the start. The edge is what's attached to Axoltis Pharma.
Spend intent
Where this round will be spent.
Hiring signals
Which departments are growing.
Verified contacts
Who actually decides.
No credit card required.
Ask AI
What is the unique value proposition of Axoltis Pharma, and who are their main competitors?
Sign up free to ask AI about Axoltis Pharma
Our AI has read their website, news, and funding history. 25 credits included with every free account.
Sign up free: 25 credits includedAuto-matched to your ICP
Every company, scored against your profile. Automatically.
Industry
High
Size
Mid
Stage
High
Match score blends industry, company size, growth stage, tech stack, and geography. The moment you set your ICP, every company in our database gets scored.
Investors
Capital Cell
Lead investor · Series A
Tech Stack
Unpkg
Contact Form 7
CookieYes
Key Highlights
AI InsightsNX210c is protected by seven patents fully owned by Axoltis Pharma, including the composition of matter, which is covered in several countries.
AI reads their website, press releases, and funding context to surface what makes them unique - so you tailor your pitch before the first call.
Try it free →Generates a personalized cold email based on their funding round, capital deployment signals, and company context. Ready to send in under 10 seconds.
Try it free →Short, personalized connection request crafted around their recent funding and what your product can help them achieve with it.
Try it free →Maps their competitive landscape with AI - invaluable context before your first call and for positioning your pitch against their alternatives.
Try it free →Extracts capital deployment signals from their funding news - reach out knowing exactly where they're investing and why your product fits.
Try it free →Similar Companies
Discover companies similar to Axoltis Pharma
Selling to Axoltis Pharma? You're in the right place.
Knowing they raised is the start. Our difference is what comes attached to Axoltis Pharma.
Spend Intent
Where this round will be spent.
Hiring Signals
Which departments are growing.
Verified Contacts
Who actually decides.
No credit card required.
Free weekly newsletter on startup funding.
20 rounds, ranked by amount. Industry and stage breakdowns. A short market note. One email, free, no noise. 2,000+ subscribers.
No spam, ever. Unsubscribe with one click.